Latest Headlines
-
Assets Of Sutro Biopharma To Be Auctioned – December 2025
9/11/2025
Late-model lab R&D and manufacturing equipment surplus to future needs of Sutro biopharma: spray dryer, chromatography systems, Westfalia separators, HPLCs & more.
-
Results Of Nanoform Collaborative Study To Be Presented At U.S. Drug Delivery & Formulation (DDF) Summit
9/11/2025
Nanoform, a leading nanoparticle medicine performance-enhancing company, announced that key findings from two studies conducted in collaboration between Nanoform and Takeda will be presented at the 15th American Drug Delivery & Formulation Summit (DDF) in Boston, Mass., on September 16, 2025, at 09:10 – 09:40 in Room 1.
-
Ridge Biotechnologies Secures $25M Seed Funding To Pioneer AI-Powered Enzyme & Drug Design
9/11/2025
Ridge Biotechnologies (Ridge Bio), a company pioneering enzyme and targeted drug design to power the next wave of precision medicines, emerged from stealth today with an oversubscribed $25 million in seed financing. Sutter Hill Ventures (SHV) incubated Ridge Bio and led the round, with participation from Overlap Holdings among others.
-
Proxio Group And Federal Equipment Announce Used Equipment Auction For September 25-30
9/10/2025
Featuring 2022 Portland Kettleworks brewhouse, fermenters, and tanks – plus centrifuged, freeze dryers, incubators, and biotech lab.
- Gilead Sciences Begins Construction On New Drug Manufacturing Facility In California 9/3/2025
- Herma US To Exhibit Robotic Labeling Cell And Front/Back/Wrap Labeling Systems At Pack Expo 2025 9/3/2025
- Amgen To Invest $600+ Million With New Science And Innovation Center In California 9/3/2025
-
CDMO Grand River Aseptic Manufacturing Announces Denis Johnson As New CEO
9/2/2025
Grand River Aseptic Manufacturing (“GRAM” or the “Company”), a portfolio company of Arlington Capital Partners, today announced the promotion of Denis Johnson to Chief Executive Officer, effective September 1, 2025. Mr. Johnson has served as President of GRAM since March 31, 2025.
-
Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture
9/2/2025
Quotient Sciences announced a new partnership with the UK CPI (Centre for Process Innovation) to help accelerate mRNA therapeutics — combining CPI capabilities in LNP manufacturing and technology with Quotient Sciences' clinical and drug product development platform, Translational Pharmaceutics®.
-
ROSS DPM-150 Double Planetary Mixer Designed For High-Volume Production In Hazardous Locations
8/28/2025
A well-proven tool for robust mixing of high-viscosity materials, the ROSS Double Planetary Mixer delivers exceptional performance through its unique agitation system and adaptability, while meeting explosion-proof requirements. The Model DPM-150 is a heavy-duty mixer that can process formulations ranging from 20 to 150 gallons, with viscosities exceeding 6 million centipoise. It is one of several ROSS production models serving thousands of pharmaceutical, aerospace, adhesives, sealants, composites, and specialty chemical manufacturing plants around the world.